Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine (vol 70, pg 1509, 2020)

被引：0
|
作者：
Levin, M. J.
Weinberg, A.
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2019年 / 69卷 / 12期
关键词：
D O I：
10.1093/cid/ciz1056
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2239 / 2239
页数：1
相关论文
共 50 条
  • [1] Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine
    Levin, Myron J.
    Weinberg, Adriana
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1509 - 1515
  • [2] Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine
    Heineman, Thomas C.
    Cunningham, Anthony
    Levin, Myron
    CURRENT OPINION IN IMMUNOLOGY, 2019, 59 : 42 - 48
  • [3] Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 195 - 196
  • [4] Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
    James, Stephanie F.
    Chahine, Elias B.
    Sucher, Allana J.
    Hanna, Cassandra
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) : 673 - 680
  • [5] Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
    Curran, D.
    Doherty, T. M.
    Lecrenier, N.
    Breuer, T.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [6] Zoster Vaccine Recombinant, Adjuvanted
    Stoker, Kalvin
    Levien, Terri L.
    Baker, Danial E.
    HOSPITAL PHARMACY, 2018, 53 (03) : 136 - 141
  • [7] Corneal Allograft Rejection Associated With Herpes Zoster Recombinant Adjuvanted Vaccine
    Matoba, Alice
    CORNEA, 2022, 41 (06) : 772 - 774
  • [8] The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy
    Lasagna, Angioletta
    Mele, Dalila
    Bergami, Federica
    Alaimo, Domiziana
    Dauccia, Chiara
    Alessio, Nicolo
    Comolli, Giuditta
    Pasi, Francesca
    Muzzi, Alba
    Novelli, Viola
    Baldanti, Fausto
    Pedrazzoli, Paolo
    Cassaniti, Irene
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [9] Adjuvanted herpes zoster subunit vaccine
    Aerssens, Annelies
    Leroux-Roels, Geert
    FUTURE VIROLOGY, 2016, 11 (01) : 5 - 18
  • [10] In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : JC5 - JC5
12345